Table of contents
December 2005 Volume 2 No 12
Top of page
Editorial
Top of page
Viewpoints
The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer
596Top of page
Research Highlights
The UbcH10 gene is a novel therapeutic target in anaplastic thyroid carcinoma
600Sensitivity to preoperative chemotherapy varies between breast cancer subtypes
600A novel preoperative staging technique for NSCLC could prevent unnecessary surgery
600Induction of antitumor immunity by partial resection and combination adjuvant therapy
601Prophylactic thyroidectomy: effective against medullary thyroid carcinoma in children
601Gene expression predicts chemotherapy response in advanced breast cancer
602Ovoid shields reduce radiation dose to the rectum during ICRT for cervical cancer
602Specific and sensitive detection of prostate cancer using urine sediment DNA
603Involved-field radiotherapy: a potential standard therapy for early stage LPHL
603Decreased dissemination and increased transgene expression using novel viral gene delivery
603P-glycoprotein expression predicts response to NACT in breast cancer
604Liver transplantation or resection for hilar cholangiocarcinoma?
605Top of page
Practice Points
Optimizing the sequencing of adjuvant chemotherapy and radiotherapy for early breast cancer
606Is radical prostatectomy of benefit in men with localized prostate cancer?
608Can dose-dense chemotherapy improve outcome in patients with better-prognosis small-cell lung cancer?
610Do low-molecular-weight heparins improve the survival of cancer patients?
612Does radiotherapy to the head, neck or upper thorax for childhood cancer increase the risk of later thyroid cancer?
614Top of page
Reviews
Epidemiology informing clinical practice: from bills of mortality to population laboratories
625doi:10.1038/ncponc0359 | Full Text | PDF (215K)
Mechanisms of Disease: prediction and prevention of breast cancer—cellular and molecular interactions
635doi:10.1038/ncponc0361 | Full Text | PDF (436K)
Top of page
Case Study

Successful pregnancies following fertility-preserving treatment for ovarian carcinoma
647doi:10.1038/ncponc0356 | Full Text | PDF (101K)


